Nouf Abdullah Almujally, Danyal Khan, Naif Al Mudawi, Mohammed Alonazi, Haifa F Alhasson, Ahmad Jalal, Hui Liu
{"title":"Wearable sensors-based assistive technologies for patient health monitoring.","authors":"Nouf Abdullah Almujally, Danyal Khan, Naif Al Mudawi, Mohammed Alonazi, Haifa F Alhasson, Ahmad Jalal, Hui Liu","doi":"10.3389/fbioe.2025.1437877","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>With the advancement of handheld devices, patient health monitoring using wearable devices plays a vital role in overall health monitoring.</p><p><strong>Methods: </strong>In this article, we have integrated multi-model bio-signals to monitor patient health data during daily life activities continuously. Two well-known datasets from ScientISST MOVE and mHealth have been analyzed. The purpose of this study is to explore the possibilities of using advanced bio-signals for monitoring patient vital signs during daily life activities and predicting favorable and more accurate health-related solutions based on current body health-related real-time measurements.</p><p><strong>Results: </strong>With the help of machine learning algorithms, we have observed classification accuracy of up to 94.67% using the mHealth dataset and 95.12% on the ScientISST MOVE dataset. Other performance indicators, such as recall, precision, and F1 score, also performed well.</p><p><strong>Discussion: </strong>Overall, integrating a machine learning model with bio-signals provides an enhanced ability to interpret complex real-time patient health monitoring for personalized care and overall smart healthcare.</p>","PeriodicalId":12444,"journal":{"name":"Frontiers in Bioengineering and Biotechnology","volume":"13 ","pages":"1437877"},"PeriodicalIF":4.8000,"publicationDate":"2025-06-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12171204/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in Bioengineering and Biotechnology","FirstCategoryId":"5","ListUrlMain":"https://doi.org/10.3389/fbioe.2025.1437877","RegionNum":3,"RegionCategory":"工程技术","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"BIOTECHNOLOGY & APPLIED MICROBIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction: With the advancement of handheld devices, patient health monitoring using wearable devices plays a vital role in overall health monitoring.
Methods: In this article, we have integrated multi-model bio-signals to monitor patient health data during daily life activities continuously. Two well-known datasets from ScientISST MOVE and mHealth have been analyzed. The purpose of this study is to explore the possibilities of using advanced bio-signals for monitoring patient vital signs during daily life activities and predicting favorable and more accurate health-related solutions based on current body health-related real-time measurements.
Results: With the help of machine learning algorithms, we have observed classification accuracy of up to 94.67% using the mHealth dataset and 95.12% on the ScientISST MOVE dataset. Other performance indicators, such as recall, precision, and F1 score, also performed well.
Discussion: Overall, integrating a machine learning model with bio-signals provides an enhanced ability to interpret complex real-time patient health monitoring for personalized care and overall smart healthcare.
期刊介绍：
The translation of new discoveries in medicine to clinical routine has never been easy. During the second half of the last century, thanks to the progress in chemistry, biochemistry and pharmacology, we have seen the development and the application of a large number of drugs and devices aimed at the treatment of symptoms, blocking unwanted pathways and, in the case of infectious diseases, fighting the micro-organisms responsible. However, we are facing, today, a dramatic change in the therapeutic approach to pathologies and diseases. Indeed, the challenge of the present and the next decade is to fully restore the physiological status of the diseased organism and to completely regenerate tissue and organs when they are so seriously affected that treatments cannot be limited to the repression of symptoms or to the repair of damage. This is being made possible thanks to the major developments made in basic cell and molecular biology, including stem cell science, growth factor delivery, gene isolation and transfection, the advances in bioengineering and nanotechnology, including development of new biomaterials, biofabrication technologies and use of bioreactors, and the big improvements in diagnostic tools and imaging of cells, tissues and organs.
In today`s world, an enhancement of communication between multidisciplinary experts, together with the promotion of joint projects and close collaborations among scientists, engineers, industry people, regulatory agencies and physicians are absolute requirements for the success of any attempt to develop and clinically apply a new biological therapy or an innovative device involving the collective use of biomaterials, cells and/or bioactive molecules. “Frontiers in Bioengineering and Biotechnology” aspires to be a forum for all people involved in the process by bridging the gap too often existing between a discovery in the basic sciences and its clinical application.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
